Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News in Focus
4/14/2026
PhRMA Warns U.S. Drug Pricing Policies Could Accelerate China's Rise i...
4/13/2026
China Outbound Biopharma Licensing Surges as Global Demand for Innovat...
4/9/2026
China Backs Independent Pricing for Innovative Drugs in Landmark State...
4/9/2026
China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...
4/7/2026
China NMPA Clears 17 Novel Drugs in First Quarter, Highlighting Sustai...
4/1/2026
Biotech VCs Move Upstream in China as Competition for Innovation Inten...
3/25/2026
IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...
3/24/2026
Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...
3/17/2026
US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...
3/12/2026
China's Labs Race for the Next First-in-Class Breakthrough
3/10/2026
China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...
3/9/2026
China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...
3/4/2026
China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
2/25/2026
China Outpaces US and EU in Drug R&D with Faster Trials and Lower Cost...
2/25/2026
Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
2/20/2026
China Biotech Kicks Off 2026 with $863 Million in January Raises
2/13/2026
China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...
2/12/2026
China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...
2/10/2026
China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
2/5/2026
China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...
1/27/2026
China's Early-Stage Drug Advantage Seen Persisting: Pitchbook
1/23/2026
China's Commercial Health Insurance Payouts for Innovative Drugs and D...
1/21/2026
China Emerges as Credible Challenger to US in AI Drug Discovery, but M...
1/17/2026
China Biopharma Innovation Takes Center Stage at 2026 FIC Summit in Sa...
1/13/2026
China Biopharma Sees Record Financing and Licensing Activity in 2025
1/13/2026
China's 2025 Foreign Investment Catalogue Unlocks Full-Chain Support f...
1/12/2026
China's Biopharma Sector Sets New Record for International Licensing D...
1/12/2026
China's Innovative Drug Licensing Deals Reach Record Peak in 2025
1/8/2026
Asia Emerges as the New Epicenter of Global Biopharma Innovation: McKi...
1/8/2026
Chinese Drug Makers Hit Record US$136B in Global Out-Licensing Deals i...
Page:
1
/
3
Total number of articles:
74
:
[First]
[<<]
[1]
[2]
[3]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit